Elutia Inc Ordinary Shares - Class A ELUT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $0.95
- Day Range
- $0.88–0.98
- 52-Week Range
- $0.50–2.50
- Bid/Ask
- $0.90 / $0.99
- Shares Outstanding
- 44.21M
- Market Cap
- $42.00M
- Volume/Avg
- 251,437 / 115,001
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.78
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- < 0.01%
Company Profile
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 26
- Website
- https://www.elutia.com
Valuation
|
Metric
|
ELUT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.90 |
Price/Sales | 2.78 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ELUT
|
|---|---|
Quick Ratio | 1.85 |
Current Ratio | 2.05 |
Interest Coverage | −75.73 |
Quick Ratio
ELUT
Profitability
|
Metric
|
ELUT
|
|---|---|
Return on Assets (Normalized) | −191.36% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −2,265.47% |
Return on Assets
ELUT
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|<l%$gP& | LOCK|Yf%@ | $175B | |||
| Stryker Corp
SYK
| LOCK|#rZ^xjJ | LOCK|lt | $123B | |||
| Medtronic PLC
MDT
| LOCK|Sk?%xl | LOCK|&jj%? | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|VthB%d | LOCK|^?%Bt | $65B | |||
| Edwards Lifesciences Corp
EW
| LOCK|#&nL?x# | LOCK|D&<!R | $49B | |||
| DexCom Inc
DXCM
| LOCK|y>xC?M!S | LOCK|%>Rw | $30B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|Q<>W<! | LOCK|q& | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|&>K | LOCK|$# | $26B | |||
| Steris PLC
STE
| LOCK|&>bj^QK | LOCK|rSSl@ | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|#!#>d!#$ | LOCK|!V | $18B |
United States